CA
PGEN icon

Cetera Advisors’s Precigen PGEN Stock Holding History

Cetera Advisors’s Portfolio PGEN Stock Details PGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$367K Buy
+252,795
New +$363K ﹤0.01% 1807

Other funds holding PGEN

PCM
Patient Capital Management Baltimore, Maryland $2.74B AUM 43.59% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Cetera Advisors's PGEN Position: Q1 2024 in Review

Cetera Advisors opened a new position in Precigen (PGEN) in Q1 2024: 252,795 shares worth $367K. The stake represents ﹤0.01% of the portfolio and ranks #1807 among its holdings.

130 funds tracked by Wall St. Rank hold PGEN as of Q1 2024.

  • Cetera Advisors held 252,795 shares of Precigen worth $367K as of Q1 2024.
  • Precigen was a new Cetera Advisors position in Q1 2024.
  • Precigen made up ﹤0.01% of Cetera Advisors's portfolio in Q1 2024, its #1807 holding.
  • 130 funds tracked by Wall St. Rank held Precigen as of Q1 2024.

Based on Cetera Advisors's 13F filing for Q1 2024, filed 15 May 2024.